cor2ed
engage checkpoint medical linkedin twitter
bg

Sequential sorafenib and regorafenib in patients with advanced HCC

Sequential sorafenib and regorafenib in patients with advanced HCC

Dr. Mohamed Bouattour

Dr. Mohamed Bouattour discusses the recently published additional analyses from the phase 3 RESORCE trial on sequential treatment with sorafenib followed by regorafenib for hepatocellular carcinoma.
Portrait of Mohamed Bouattour
Dr. Mohamed Bouattour

Hepatologist and Gastroenterologist

Beaujon University Hospital

France

preview next

time Expert View | open 5 min

download resources

I agree that this educational programme:

Was valuable to me:

1/3

Other programmes of interest